Frohman EM, Racke MK, Raine CS: Multiple sclerosis–the plaque and its pathogenesis. N Engl J Med. 2006, 354: 942-955. 10.1056/NEJMra052130.
Article
CAS
PubMed
Google Scholar
Compston A, Coles A: Multiple sclerosis. Lancet. 2008, 372: 1502-1517. 10.1016/S0140-6736(08)61620-7.
Article
CAS
PubMed
Google Scholar
Castegna A, Palmieri L, Spera I, Porcelli V, Palmieri F, Fabis-Pedrini MJ, Kean RB, Barkhouse DA, Curtis MT, Hooper DC: Oxidative stress and reduced glutamine synthetase activity in the absence of inflammation in the cortex of mice with experimental allergic encephalomyelitis. Neuroscience. 2011, 185: 97-105.
Article
CAS
PubMed
Google Scholar
Miller DM, Weinstock-Guttman B, Béthoux F, Lee JC, Beck G, Block V, Durelli L, LaMantia L, Barnes D, Sellebjerg F, Rudick RA: A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Mult Scler. 2000, 6: 267-273. 10.1177/135245850000600408.
Article
CAS
PubMed
Google Scholar
Cohen JA, Goodman AD, Heidenreich FR: Results of IMPACT. A phase 3 trial of interferon beta-1a in secondary progressive multiple sclerosis. Neurology. 2001, 56: S20.003-
Google Scholar
Comi G, Fillippi M, Wolinsky JS: European/Canadian multicenter, double blind, randomized, placebocontrolled study of the effects of glatiramer acetate on magnetic resonance imaging- measured disease activity and burden in patients with relapsing multiple sclerosis. European/Canadian Glatiramer Acetate Study Group. Ann Neurol. 2001, 49: 290-297. 10.1002/ana.64.
Article
CAS
PubMed
Google Scholar
Cursiefen S, Flachenecker P, Toyka KV, Rieckmann P: Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis. Eur Neurol. 2000, 43: 186-187. 10.1159/000008163.
Article
CAS
PubMed
Google Scholar
Yudkin PL, Ellison GW, Ghezzi A, Goodkin DE, Hughes RA, McPherson K, Mertin J, Milanese C: Overview of azathioprine treatment in multiple sclerosis. Lancet. 1991, 338: 1051-1055. 10.1016/0140-6736(91)91909-E.
Article
CAS
PubMed
Google Scholar
Comabella M, Balashov K, Issazadeh S, Smith D, Weiner HL, Khoury SJ: Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest. 1998, 102: 671-678. 10.1172/JCI3125.
Article
CAS
PubMed
PubMed Central
Google Scholar
Achiron A, Gabbay U, Gilad R, Hassin-Baer S, Barak Y, Gornish M, Elizur A, Goldhammer Y, Sarova-Pinhas I: Intravenous immunoglobulin treatment in multiple sclerosis: effect on relapses. Neurology. 1998, 50: 398-402. 10.1212/WNL.50.2.398.
Article
CAS
PubMed
Google Scholar
Weinshenker BG, O'Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriquez M: A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999, 46: 878-886. 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q.
Article
CAS
PubMed
Google Scholar
Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR: Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol. 2002, 52: 421-428. 10.1002/ana.10301.
Article
CAS
PubMed
Google Scholar
Neuhaus O, Strasser-Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, Hartung HP, Archelos JJ: Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology. 2002, 59: 990-997. 10.1212/WNL.59.7.990.
Article
CAS
PubMed
Google Scholar
Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW: International natalizumab multiple sclerosis trial group: a controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2003, 348: 15-23. 10.1056/NEJMoa020696.
Article
CAS
PubMed
Google Scholar
Castro-Borrero W, Graves D, Frohman TC, Flores AB, Hardeman P, Logan D, Orchard M, Greenberg B, Frohman EM: Current and emerging therapies in multiple sclerosis: a systematic review. Ther Adv Neurol Disord. 2012, 5: 205-220. 10.1177/1756285612450936.
Article
PubMed
PubMed Central
Google Scholar
E-Morris M, Caldwell B, Mencher KJ, Grogan K, Judge-Gorny M, Patterson Z, Christopher T, Smith RC, McQuaide T: Nurse-directed care model in a psychiatric hospital: a model for clinical accountability. Clin Nurse Spec. 2010, 24: 154-160. 10.1097/NUR.0b013e3181d82b6c.
Article
PubMed
Google Scholar
Wu X, Pan W, He Y, Hsuchou H, Kastin AJ: Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2010, 223: 65-72. 10.1016/j.jneuroim.2010.04.001.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moon C, Kim S, Wie M, Kim H, Cheong J, Park J, Jee Y, Tanuma N, Matsumoto Y, Shin T: Increased expression of p53 and Bax in the spinal cords of rats with experimental autoimmune encephalomyelitis. Neurosci Lett. 2000, 289: 41-44. 10.1016/S0304-3940(00)01253-2.
Article
CAS
PubMed
Google Scholar
Rios JL, Waterman PG: A review of the pharacology and toxicology of Astragalus. Phytother Res. 1997, 11: 411-418. 10.1002/(SICI)1099-1573(199709)11:6<411::AID-PTR132>3.0.CO;2-6.
Article
CAS
Google Scholar
Liu G, Song J, Guo Y, Wang T, Zhou Z: Astragalus injection protects cerebral ischemic injury by inhibiting neuronal apoptosis and the expression of JNK3 after cerbral ischemic reperfusion in rats. Behav Brain Funct. 2013, 9: 36-10.1186/1744-9081-9-36.
Article
PubMed
PubMed Central
Google Scholar
Cheng CY, Yao CH, Liu BS, Liu CJ, Chen GW, Chen YS: The role of astragaloside in regeneration of the peripheral nerve system. J Biomed Mater Res A. 2006, 76: 463-469.
Article
PubMed
Google Scholar
Lei H, Wang B, Li WP, Yang Y, Zhou AW, Chen MZ: Anti-aging effect of astragalosides and its mechanism of action. Acta Pharmacol Sin. 2003, 24: 230-234.
CAS
PubMed
Google Scholar
Li WZ, Wu WY, Huang DK, Yin YY, Kan HW, Wang X, Yao YY, Li WP: Protective effects of astragalosides on dexamethasone and Aβ25-35 induced learning and memory impairments due to decrease amyloid precursor protein expression in 12-month male rats. Food Chem Toxicol. 2012, 50: 1883-1890. 10.1016/j.fct.2012.03.064.
Article
CAS
PubMed
Google Scholar
Xu M, Yin J, Xie L, Zhang J, Zou C, Zou J, Liu F, Ju W, Li P: Pharmacokinetics and tolerance of toal astragalosides after intravenous infusion of astragalosides injection in healthy Chinese volunteers. Phytomedicine. 2013, 20: 1105-1111. 10.1016/j.phymed.2013.05.004.
Article
CAS
PubMed
Google Scholar
He YX, Du M, Gao Y, Liu HS, Wang HW, Wu XJ, Wang ZT: Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels. PLoS One. 2013, 8: e76495-10.1371/journal.pone.0076495.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Z, Du M, Wu X, Zhou J, Wang Z, Hu Z: Detection the content of Astragaloside IV in Astragalus membranaceus by HPLC-ELSD. Shanghai Zhong Yi Yao Da Xue Xue Bao. 2010, 24: 85-87.
Google Scholar
Peiris M, Monteith GR, Roberts-Thomson SJ, Cabot PJ: A model of experimental autoimmune encephalomyelitis (EAE) in C57BL/6 mice for the characterisation of intervention therapies. J Neurosci Methods. 2007, 163: 245-254. 10.1016/j.jneumeth.2007.03.013.
Article
CAS
PubMed
Google Scholar
Schreibelt G, van Horssen J, Haseloff RF, Reijerkerk A, van der Pol SM, Nieuwenhuizen O, Krause E, Blasig IE, Dijkstra CD, Ronken E, De Vries HE: Protective effects of peroxiredoxin-1 at the injured blood-brain barrier. Free Radic Biol Med. 2008, 45: 256-264. 10.1016/j.freeradbiomed.2008.03.024.
Article
CAS
PubMed
Google Scholar
Uzar E, Koyuncuoglu HR, Uz E, Yilmaz HR, Kutluhan S, Kukbas Sm Gyktejub F: The activities of antioxidant enzymes and the level of malondialdehyde in cerebellum of rats subjected to the level of malondialdehyde in cerebellum of rats subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem. 2006, 291: 63-68. 10.1007/s11010-006-9196-5.
Article
CAS
PubMed
Google Scholar
Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM: IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med. 2008, 205: 1535-1541. 10.1084/jem.20080159.
Article
CAS
PubMed
PubMed Central
Google Scholar
Siffrin V, Radbruch H, Glumm R, Niesner R, Paterka M, Herz J, Leuenberger T, Lehmann SM, Luenstedt S, Rinnenthal JL, Laube G, Luche H, Lehnardt S, Fehling HJ, Griesbeck O, Zipp F: In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity. 2010, 33: 424-436. 10.1016/j.immuni.2010.08.018.
Article
CAS
PubMed
Google Scholar
Suri-Payer E, Fritzsching B: Regulatory T cells in experimental autoimmune disease. Springer Semin Immunopathol. 2006, 28: 3-16. 10.1007/s00281-006-0021-8.
Article
CAS
PubMed
Google Scholar
Bettelli E, Korn T, Oukka M, Kuchroo VK: Induction and effector functions of T (H)17 cells. Nature. 2008, 453: 1051-1057. 10.1038/nature07036.
Article
CAS
PubMed
Google Scholar
Zhang L, Zhao Y: The regulation of Foxp3 expression in regulatory CD4 (+) CD25 (+) T cells: multiple pathways on the road. J Cell Physiol. 2007, 211: 590-597. 10.1002/jcp.21001.
Article
CAS
PubMed
Google Scholar
Floris S, Blezer EL, Schreibelt G, Döpp E, van der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CD, de Vries HE: Blood–brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain. 2004, 127: 616-627.
Article
CAS
PubMed
Google Scholar
Schreibelt G, Musters RJ, Reijerkerk A, de Groot LR, van der Pol SM, Hendrikx EM, Döpp ED, Dijkstra CD, Drukarch B, de Vries HE: Lipoic acid affects cellular migration into the central nervous system and stabilizes blood–brain barrier integrity. J Immunol. 2006, 177: 2630-2637. 10.4049/jimmunol.177.4.2630.
Article
CAS
PubMed
Google Scholar
Gilgun-Sherki Y, Melamed E, Offen D: The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol. 2004, 251: 261-268. 10.1007/s00415-004-0348-9.
Article
CAS
PubMed
Google Scholar
Lagrange P, Romero IA, Minn A, Revest PA: Transendothelial permeability changes induced by free radicals in an in vitro model of the blood–brain barrier. Free Radic Biol Med. 1999, 27: 667-672. 10.1016/S0891-5849(99)00112-4.
Article
CAS
PubMed
Google Scholar
Eng LF, Vanderhaeghen JJ, Bignami A, Gerstl B: An acidic protein isolated from fibrous astrocytes. Brain Res. 1971, 28: 351-354. 10.1016/0006-8993(71)90668-8.
Article
CAS
PubMed
Google Scholar
Smith ME, Somera FP, Eng LF: Immunocytochemical staining for glial fibrillary acidic protein and the metabolism of cytoskeletal proteins in experimental allergic encephalomyelitis. Brain Res. 1983, 264: 241-253. 10.1016/0006-8993(83)90822-3.
Article
CAS
PubMed
Google Scholar
Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, Sofroniew MV: Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci. 2009, 29: 11511-11522. 10.1523/JNEUROSCI.1514-09.2009.
Article
CAS
PubMed
PubMed Central
Google Scholar
Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH: Mechanisms underlying inflammation in neurodegeneration. Cell. 2010, 140: 918-934. 10.1016/j.cell.2010.02.016.
Article
CAS
PubMed
PubMed Central
Google Scholar
Spencer JP, Vafeiadou K, Williams RJ, Vauzour D: Neuroinflammation: modulation by flavonoids and mechanisms of action. Mol Aspects Med. 2012, 33: 83-97. 10.1016/j.mam.2011.10.016.
Article
CAS
PubMed
Google Scholar
Cory S, Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002, 2: 647-656. 10.1038/nrc883.
Article
CAS
PubMed
Google Scholar
Tanaka K, Asanuma M, Ogawa N: Molecular basis of anti-apoptotic effect of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells. Neurochem Res. 2004, 29: 1529-1536.
Article
CAS
PubMed
Google Scholar